INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 265 filers reported holding INTRA CELLULAR THERAPIES INC in Q2 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,566,268 | -17.7% | 260,439 | 0.0% | 1.22% | -15.3% |
| Q2 2023 | $16,490,997 | +16.9% | 260,439 | 0.0% | 1.44% | +7.6% |
| Q1 2023 | $14,102,772 | -6.0% | 260,439 | -8.1% | 1.33% | -9.1% |
| Q4 2022 | $14,999,592 | +13.7% | 283,439 | 0.0% | 1.47% | +7.0% |
| Q3 2022 | $13,188,000 | -18.5% | 283,439 | 0.0% | 1.37% | -15.6% |
| Q2 2022 | $16,179,000 | -6.7% | 283,439 | 0.0% | 1.62% | +14.8% |
| Q1 2022 | $17,344,000 | +16.9% | 283,439 | 0.0% | 1.42% | +21.8% |
| Q4 2021 | $14,835,000 | +13.4% | 283,439 | -19.2% | 1.16% | +4.9% |
| Q3 2021 | $13,078,000 | -8.7% | 350,804 | 0.0% | 1.11% | -7.5% |
| Q2 2021 | $14,320,000 | +21.4% | 350,804 | +1.0% | 1.20% | +8.9% |
| Q1 2021 | $11,791,000 | +6.7% | 347,497 | 0.0% | 1.10% | +0.7% |
| Q4 2020 | $11,050,000 | +23.9% | 347,497 | 0.0% | 1.09% | +6.2% |
| Q3 2020 | $8,917,000 | +30.3% | 347,497 | +30.4% | 1.03% | +18.5% |
| Q2 2020 | $6,842,000 | +67.0% | 266,527 | 0.0% | 0.87% | +56.4% |
| Q1 2020 | $4,097,000 | -64.0% | 266,527 | -19.6% | 0.56% | -46.7% |
| Q4 2019 | $11,375,000 | +345.9% | 331,527 | -2.9% | 1.04% | +313.5% |
| Q3 2019 | $2,551,000 | -34.5% | 341,527 | +13.9% | 0.25% | -31.7% |
| Q2 2019 | $3,893,000 | +6.6% | 299,942 | 0.0% | 0.37% | +1.9% |
| Q1 2019 | $3,653,000 | +6.9% | 299,942 | 0.0% | 0.36% | +0.8% |
| Q4 2018 | $3,416,000 | – | 299,942 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DCF Advisers, LLC | 359,000 | $18,790,000 | 7.62% |
| Velan Capital Investment Management LP | 150,000 | $7,851,000 | 6.09% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 195,000 | $10,206,000 | 4.14% |
| Vantage Consulting Group Inc | 226,670 | $11,864,000 | 3.19% |
| Vahanian & Associates Financial Planning Inc. | 71,742 | $3,755,000 | 3.03% |
| Nicholas Investment Partners, LP | 652,886 | $34,172,000 | 2.16% |
| COOPER/HAIMS ADVISORS, LLC | 61,116 | $3,199,000 | 1.97% |
| Bellevue Group AG | 3,628,919 | $189,938,000 | 1.96% |
| WASATCH ADVISORS LP | 8,235,171 | $431,029,000 | 1.76% |
| Quantum Private Wealth, LLC | 77,622 | $4,062,000 | 1.54% |